Replimune Group
REPL
107 hedge funds and large institutions have $665M invested in Replimune Group in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 13 closing their positions.
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
34% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 29
8% more funds holding
Funds holding: 99 → 107 (+8)
0.06% more ownership
Funds ownership: 82.8% → 82.86% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
37% less capital invested
Capital invested by funds: $1.05B → $665M (-$386M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$19.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.71M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.65M |
| 4 |
Morgan Stanley
New York
|
+$4.44M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$30.1M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$24.5M |
| 3 |
FM
Frazier Management
Seattle,
Washington
|
-$17.6M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$17.2M |
| 5 |
JP Morgan Chase
New York
|
-$6.83M |
REPL Hedge Fund Activity: Q1 2022 in Review
107 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q1 2022, worth a combined $665M — down 37% from $1.05B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new REPL positions and 13 closed out — a net gain of 8 holders — while 39 added to existing stakes and 29 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $19.2M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $30.1M sold.
- 107 institutional investors held Replimune Group (REPL) as of Q1 2022, up from 99 in Q4 2021.
- Funds reported $665M of Replimune Group stock for Q1 2022, down 37% quarter-over-quarter.
- 21 funds opened new Replimune Group positions in Q1 2022 and 13 closed out, a net change of +8 holders.
- The largest Replimune Group buyer in Q1 2022 was Baker Bros. Advisors, an estimated $19.2M added.
- The largest Replimune Group seller in Q1 2022 was Loomis, Sayles & Company, an estimated $30.1M sold.
Based on aggregated 13F filings for Q1 2022.